This opportunity has closed

The submission deadline was January 13, 2026. This page is kept for reference purposes.

ACAN-Botulinum Antitoxin Heptavalent

Department of Public Works and Government Services (PSPC)
canadabuys Posted: December 11, 2025

OPPORTUNITY SUMMARY: ACAN-Botulinum Antitoxin Heptavalent --- PURPOSE & SCOPE: Procurement Description: The opportunity is for the manufacture and storage of Botulinum Antitoxin (BAT) Bulk Drug Substance as well as BAT in finished dosage form. Project Scope and Objectives: The objective is to secure...

Read full summary
Due Date
January 13, 2026
(Overdue)
Solicitation #
WS5474605028

Actions

Create a free account to analyze this opportunity, get daily notifications, and win more bids with Narwin.ai

Description

Manufacture and store BAT Bulk Drug Substance as well as BAT in finished dosage form

Additional Information

Amendment Number

000

Contact Info Email

Contact Info Name

Duplin-Vu, Kim-Andre (SPAC/PSPC)

Contracting Entity Name

Department of Public Works and Government Services (PSPC)

Created

December 12, 2025

Is Public

true

Limited Tendering Reason

Exclusive Rights

Organization Address City

Gatineau

Organization Country

Canada

Organization Address Line

11 Laurier St, Phase III, Place du Portage

Organization Address Postal Code

K1A 0S5

Organization Address Province

Quebec

Procurement Category

*GD

Procurement Method

Advance contract award notice

Reference Number

WS5474605028-Doc5479770561

Regions Of Delivery

*Canada

Selection Criteria

Not applicable

Source

canadabuys

Source Record ID

WS5474605028-Doc5479770561_000

Source System

canadabuys

Status

closed

Status En

closed

Summary Updated At

December 13, 2025

Tender Closing Date

January 13, 2026

Last Updated

July 29, 2026

Frequently Asked Questions

When is the proposal submission deadline?

The proposal submission deadline is January 13, 2026 (Overdue).

Note: This opportunity has already closed. See similar active opportunities above.

AI Summary

OPPORTUNITY SUMMARY: ACAN-Botulinum Antitoxin Heptavalent


PURPOSE & SCOPE:

  • Procurement Description: The opportunity is for the manufacture and storage of Botulinum Antitoxin (BAT) Bulk Drug Substance as well as BAT in finished dosage form.
  • Project Scope and Objectives: The objective is to secure a reliable source of both bulk and finished BAT to meet public health requirements.
  • Contract Type and Estimated Value: Specific contract type and estimated value have not been provided in the opportunity details.

BUYER INFORMATION:

  • Issuing Organization: Department of Public Works and Government Services (PSPC)
  • Contact Details: Kim-Andre Duplin-Vu (SPAC/PSPC) - Email: [email protected]
  • Important Dates:
    • Posted Date: December 11, 2025
    • Due Date: January 13, 2026
    • Performance Period: Not specified

MANDATORY REQUIREMENTS:

  • Required Certifications/Registrations: Information on specific certifications or registrations required has not been provided.
  • Mandatory Qualifications: Not specified in the available data.
  • Set-aside Requirements: No information available regarding small business or veteran-owned set-asides.
  • Geographic Restrictions: No geographic restrictions mentioned.

TECHNICAL REQUIREMENTS:

  • Key Technical Capabilities Needed: Companies must possess capabilities in the manufacture and storage of pharmaceutical products, specifically botulinum antitoxins.
  • Specific Technologies/Methodologies: Not explicitly mentioned; expectations may require adherence to pharmaceutical manufacturing and safety regulations.
  • Deliverables and Performance Standards: Specific deliverables and performance standards have not been detailed.
  • Evaluation Criteria: No specific evaluation criteria provided.

PREFERRED QUALIFICATIONS:

  • Nice-to-have Certifications or Experience: No additional certifications or experience requirements specified.
  • Preferred Qualifications: No specific qualifications mentioned beyond necessary capabilities for the manufacture of BAT.
  • Competitive Advantage Factors: None listed in the documentation.

KEY EVALUATION FACTORS:

  • Proposal Evaluation: Details on how proposals will be evaluated are not included.
  • Weighting of Criteria: Not mentioned.
  • Past Performance Requirements: No information regarding past performance requirements.

This structured summary provides an overview of the ACAN-Botulinum Antitoxin Heptavalent opportunity. Companies interested in this opportunity should focus on developing capabilities for the manufacture and storage of pharmaceutical products, particularly in line with public health requirements.

Narwin.ai is a great way to find government contracts and opportunities. Disclaimer: This bid/tender/opportunity information is presented as is and may be incorrect at times. Please read the tender documents carefully before finalizing bids. We do not accept any responsibility and cannot be held legally liable for any inaccuracies.